Effect of d-amphetamine on brain protein synthesis

H. Loh, Robert Hitzemann, S. Stolman

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The effect of high to lethal doses of d-amphetamine on the incorporation of radiolabeled leucine into brain microsomal protein was studied in mice. High doses of d-amphetamine ranging from 30 to 100 mg/kg significantly inhibited protein synthesis 1 hr after ip injection, whereas smaller doses were ineffective. The addition of d-amphetamine to the microsomal incubation system at concentrations greater than 5 mm likewise inhibited protein synthesis. The in vivo and in vitro inhibitory effect was attributed to a drug-induced alteration of the soluble fraction rather than of the brain microsomes.

Original languageEnglish (US)
Pages (from-to)476-481
Number of pages6
JournalToxicology and Applied Pharmacology
Volume26
Issue number3
DOIs
StatePublished - 1973
Externally publishedYes

Fingerprint

Dextroamphetamine
Brain
Proteins
Microsomes
Leucine
Injections
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Effect of d-amphetamine on brain protein synthesis. / Loh, H.; Hitzemann, Robert; Stolman, S.

In: Toxicology and Applied Pharmacology, Vol. 26, No. 3, 1973, p. 476-481.

Research output: Contribution to journalArticle

@article{21c554606ee2427eb063c765eab33301,
title = "Effect of d-amphetamine on brain protein synthesis",
abstract = "The effect of high to lethal doses of d-amphetamine on the incorporation of radiolabeled leucine into brain microsomal protein was studied in mice. High doses of d-amphetamine ranging from 30 to 100 mg/kg significantly inhibited protein synthesis 1 hr after ip injection, whereas smaller doses were ineffective. The addition of d-amphetamine to the microsomal incubation system at concentrations greater than 5 mm likewise inhibited protein synthesis. The in vivo and in vitro inhibitory effect was attributed to a drug-induced alteration of the soluble fraction rather than of the brain microsomes.",
author = "H. Loh and Robert Hitzemann and S. Stolman",
year = "1973",
doi = "10.1016/0041-008X(73)90284-6",
language = "English (US)",
volume = "26",
pages = "476--481",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Effect of d-amphetamine on brain protein synthesis

AU - Loh, H.

AU - Hitzemann, Robert

AU - Stolman, S.

PY - 1973

Y1 - 1973

N2 - The effect of high to lethal doses of d-amphetamine on the incorporation of radiolabeled leucine into brain microsomal protein was studied in mice. High doses of d-amphetamine ranging from 30 to 100 mg/kg significantly inhibited protein synthesis 1 hr after ip injection, whereas smaller doses were ineffective. The addition of d-amphetamine to the microsomal incubation system at concentrations greater than 5 mm likewise inhibited protein synthesis. The in vivo and in vitro inhibitory effect was attributed to a drug-induced alteration of the soluble fraction rather than of the brain microsomes.

AB - The effect of high to lethal doses of d-amphetamine on the incorporation of radiolabeled leucine into brain microsomal protein was studied in mice. High doses of d-amphetamine ranging from 30 to 100 mg/kg significantly inhibited protein synthesis 1 hr after ip injection, whereas smaller doses were ineffective. The addition of d-amphetamine to the microsomal incubation system at concentrations greater than 5 mm likewise inhibited protein synthesis. The in vivo and in vitro inhibitory effect was attributed to a drug-induced alteration of the soluble fraction rather than of the brain microsomes.

UR - http://www.scopus.com/inward/record.url?scp=0015846089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015846089&partnerID=8YFLogxK

U2 - 10.1016/0041-008X(73)90284-6

DO - 10.1016/0041-008X(73)90284-6

M3 - Article

C2 - 4767582

AN - SCOPUS:0015846089

VL - 26

SP - 476

EP - 481

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 3

ER -